Form 8-K - Current report:
SEC Accession No. 0001104659-25-046149
Filing Date
2025-05-08
Accepted
2025-05-08 16:21:42
Documents
16
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514150d1_8k.htm   iXBRL 8-K 33949
2 EXHIBIT 99.1 tm2514150d1_ex99-1.htm EX-99.1 51506
7 GRAPHIC tm2514150d1_ex99-1img01.jpg GRAPHIC 7356
  Complete submission text file 0001104659-25-046149.txt   325526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20250508.xsd EX-101.SCH 3892
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20250508_def.xml EX-101.DEF 26797
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20250508_lab.xml EX-101.LAB 37059
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20250508_pre.xml EX-101.PRE 25421
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2514150d1_8k_htm.xml XML 6093
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 25926566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)